CMPX vs PLTR · $367.4M cap vs P/E 584, rev $4.48B
Compass Therapeutics Inc. (CMPX) versus Palantir Technologies Inc. Class A Common Stock (PLTR) — a side-by-side from cached financials, not a winner call.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
CMPX does not have a complete income-statement cache yet.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
CMPX currently screens at market cap $367.4M. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Not investment advice. Open the CMPX and PLTR stock pages for the full models.
Not investment advice.